GSK926 (compound 3) is a selective histone lysine methyltransferase EZH2 inhibitor (IC50=0.02 µM, Ki=7.9 nM), with SAM-competitive and cell-active properties. GSK926 can be used in cancer research[1].
Molecular Weight:
513.63
CAS Number:
[1346704-13-9]
Formula:
C29H35N7O2
Target:
Histone Methyltransferase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
